Comparative study of CA242 and CA19-9 in chronic pancreatitis
1996

Comparative study of CA242 and CA19-9 in chronic pancreatitis

Sample size: 70 publication Evidence: moderate

Author Information

Author(s): N Furuya, S Kawa, O Hasebe, M Tokoo, K Mukawa, S Maejima, H Oguchi

Primary Institution: Shinshu University School of Medicine

Hypothesis

The study aims to clarify the mechanisms contributing to the high specificity of CA242 compared to CA19-9 in patients with chronic pancreatitis.

Conclusion

CA242 levels are less influenced by stagnation of pancreatic juice than CA19-9 levels in chronic pancreatitis.

Supporting Evidence

  • CA242 was expressed less frequently and intensely than CA19-9 in chronic pancreatitis tissues.
  • Serum CA19-9 levels were significantly elevated in patients with calcification and MPD stenosis or obstruction.
  • CA242 showed a specificity of 86%, higher than CA19-9's 76% in chronic pancreatitis.

Takeaway

This study found that CA242 is a better marker than CA19-9 for diagnosing pancreatic cancer in patients with chronic pancreatitis because it doesn't rise as much in benign conditions.

Methodology

Serum levels were measured and correlated with ERCP findings and immunohistochemical analysis in patients with chronic pancreatitis.

Limitations

The study had a small number of patients with complications, which may limit the generalizability of the findings.

Participant Demographics

Patients included 47 with alcoholic pancreatitis and 23 with idiopathic pancreatitis.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication